INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children. What is the most important …

2019年8月16日 · Inrebic是一种激酶抑制剂，用于治疗中度-2或高危原发性或继发性（红细胞增多症后或原发性血小板增多症后）骨髓纤维化（MF）的成人患者。 用法用量：

INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) …

菲卓替尼适应症：美国食品和药物管理局（FDA）批准INREBIC（fedratinib、菲卓替尼）用于治疗患有中度或高风险原发性或继发性（继发于真性红细胞增多症或原发性血小板增多症后）骨髓 …

2024年12月3日 · Inrebic is used to treat intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis in adults. The most …

Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. [6] It is used in the form of fedratinib …

INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis...

2020年12月11日 · Inrebic is a medicine used to treat adults with myelofibrosis (a rare form of blood cancer) who have enlarged spleen or other symptoms related to the disease.

INREBIC® (fedratinib) is a treatment for adult patients with INT-2 or high-risk myelofibrosis. See full Prescribing Information, including Boxed Warning on encephalopathy, including Wernicke's.

2024年12月4日 · What is INREBIC? INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children. …